EU health regulator backs Pfizer’s RSV vaccine for infants, older adults

This post was originally published on this site

The shot, called Abrysvo, could become the first vaccine in the bloc to protect infants from the virus, if the European Commission authorizes its use.

Pfizer’s shot is already approved in the United States for protection against RSV in older adults.

RSV typically causes cold-like symptoms, and is a leading cause of pneumonia in toddlers and older adults.